IP Library › Granted Patent US 12,576,247
Granted Patent B2
US 12,576,247 · App. 18/644,816 · Granted Mar 17, 2026

Introducer sheath systems and methods

Inventors: Kyle P. Taylor (Greenfield, MN); Michael Brenzel (St. Paul, MN); David Matthew Costello (Delano, MN); Robert E. Atkinson (White Bear Lake, MN)
Assignee: Cultiv8 Medical, LLC
A61M25/0662A61M25/0097A61M29/00A61M39/0613A61M2039/062A61M2039/0626A61M2039/0673A61M2205/0216A61M2205/3331A61M2205/583
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,576,247
App. No.
18/644,816
Granted
Mar 17, 2026
Kind
B2
Abstract

Introducer sheath systems including a pressure regulator operably coupled to a hemostatic valve, wherein the pressure regulator includes a chamber filled with a gas that is fluidly isolated from the hemostatic valve. The introducer sheath systems may include a tubular sheath, a hub assembly, and a dilator disposed therein connected to a proximal end of the sheath; the hub assembly including a housing and a hemostatic valve disposed therein; a pressure regulator connected to the hub and in fluid communication with the hemostatic valve; and a sealed chamber defined by the pressure regulator, the chamber having an interior, wherein the interior of the chamber is filled with a gas that is fluidly isolated from the hemostatic valve.

Claims (39)

1 . An introducer sheath system, comprising:

a tubular sheath;

a hub assembly connected to a proximal end of the tubular sheath;

a dilator extending through the hub assembly and the tubular sheath;

the hub assembly including a housing and a hemostatic valve disposed therein;

the hemostatic valve comprising a rigid valve body and a collapsible member, wherein the collapsible member closes when a space between the collapsible member and the rigid valve body is pressurized;

a pressure regulator connected to the hub assembly and in fluid communication with the space between the collapsible member and the rigid valve body; and

a sealed chamber including a closed-cell foam defined by the pressure regulator, the sealed chamber having an interior, wherein the interior of the sealed chamber is fluidly isolated from the space between the collapsible member and the rigid valve body.

2 . The introducer sheath system as in claim 1 , wherein the collapsible member is connected to the rigid valve body.

3 . The introducer sheath system as in claim 1 , wherein the space between the collapsible member and the rigid valve body is filled with a liquid.

4 . The introducer sheath system as in claim 3 , wherein the sealed chamber is filled with a gas.

5 . The introducer sheath system as in claim 4 , wherein the collapsible member comprises a sleeve.

6 . The introducer sheath system as in claim 5 , wherein the collapsible member comprises ePTFE.

7 . The introducer sheath system as in claim 5 , wherein the collapsible member comprises densified ePTFE.

8 . The introducer sheath system as in claim 5 , wherein the collapsible member comprises a laminate of FEP over ePTFE.

9 . The introducer sheath system as in claim 5 , wherein the collapsible member is inverted and wrapped around ends of the rigid valve body.

10 . The introducer sheath system as in claim 1 , wherein the pressure regulator mitigates a valve pressure increase as a function of a device size at a rate less than 0.70 PSI/F.

11 . The introducer sheath system as in claim 1 , wherein the pressure regulator mitigates a valve pressure increase as a function of a device size at a rate less than 0.50 PSI/F.

12 . The introducer sheath system as in claim 1 , wherein the pressure regulator mitigates a valve pressure increase as a function of a device size at a rate less than 0.35 PSI/F.

13 . An introducer sheath system, comprising:

a tubular sheath;

a hub assembly connected to a proximal end of the tubular sheath, the hub assembly including a primary port and a secondary port;

a dilator extending through the primary port, the hub assembly and the tubular sheath;

the hub assembly including a housing and a hemostatic valve disposed therein;

the hemostatic valve comprising a rigid valve body and a collapsible member, wherein the collapsible member closes when a space between the collapsible member and the rigid valve body is pressurized;

a pressure regulator connected to the hub assembly and in fluid communication with the space between the collapsible member and the rigid valve body; and

a sealed chamber including a closed-cell foam defined by the pressure regulator, the sealed chamber having an interior, wherein the interior of the sealed chamber is fluidly isolated from the space between the collapsible member and the rigid valve body.

14 . The introducer sheath system as in claim 13 , wherein the housing of the hub assembly defines a bubble capture chamber with a vertical apex, and wherein a flush line is connected to the bubble capture chamber at the vertical apex to vent air bubbles from the bubble capture chamber.

15 . The introducer sheath system as in claim 14 , wherein the housing defining the bubble capture chamber is transparent to facilitate viewing bubbles in the bubble capture chamber.

16 . The introducer sheath system as in claim 13 , further comprising a brake connected to the housing of the hub assembly, wherein the brake is configured to engage a device inserted into at least one of the primary port and the secondary port.

17 . The introducer sheath system as in claim 13 , wherein the hub assembly includes a connector associated with one of the primary or secondary ports, wherein the connector is configured for connection to ECMO tubing for receiving oxygenated blood flow.

18 . An introducer sheath, comprising:

a tubular sheath;

a hub assembly connected to a proximal end of the tubular sheath;

the hub assembly including a housing and a hemostatic valve disposed therein;

a pressure regulator connected to the hub assembly and in fluid communication with the hemostatic valve; and

a sealed chamber including a closed-cell foam defined by the pressure regulator, the sealed chamber having an interior, wherein the interior of the sealed chamber is filled with a gas that is fluidly isolated from the hemostatic valve.

19 . The introducer sheath according to claim 18 , further comprising anchor wings mounted to a base of the assembly hub, the anchor wings configured to anchor the assembly hub to a vascular access site.

20 . The introducer sheath according to claim 18 , wherein the hemostatic valve includes a valve body and a collapsible member, and wherein the collapsible member is secured to the valve body by an O-ring.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2025
From: CULTIV8 1, LLC
To: CULTIV8 MEDICAL, LLC
Reel/Frame 070262/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2024
From: TAYLOR, KYLE P.; BRENZEL, MICHAEL; COSTELLO, DAVID MATTHEW; ATKINSON, ROBERT E.
To: CULTIV8 1, LLC
Reel/Frame 068554/0711 →
Continuity (4)
Provisional Application 63591928 · Oct 20, 2023
Provisional Application 63512740 · Jul 10, 2023
Provisional Application 63498637 · Apr 27, 2023
Related Publication 20240358975A1 · Oct 31, 2024
References Cited (43)
US 4540411A · Bodicky · 1985 [cited by applicant]
US 4580573A · Quinn · 1986 [cited by applicant]
US 5071411A · Hillstead · 1991 [cited by applicant]
US 5161773A · Tower · 1992 [cited by examiner]
US 5360417A · Gravener et al. · 1994 [cited by applicant]
US 5401248A · Bencini · 1995 [cited by applicant]
US 5556387A · Mollenauer et al. · 1996 [cited by applicant]
US 5782817A · Franzel et al. · 1998 [cited by applicant]
US 5871474A · Hermann et al. · 1999 [cited by applicant]
US 5895376A · Schwartz et al. · 1999 [cited by applicant]
US 5989233A · Yoon · 1999 [cited by applicant]
US 6221057B1 · Schwartz et al. · 2001 [cited by applicant]
US 6238373B1 · de la Torre et al. · 2001 [cited by applicant]
US 7673846B2 · Jennings et al. · 2010 [cited by applicant]
US 8002749B2 · Macatangay et al. · 2011 [cited by applicant]
US 8118784B2 · Molgaard-Nielsen · 2012 [cited by applicant]
US 8137321B2 · Argentine · 2012 [cited by applicant]
US 8235943B2 · Breznock et al. · 2012 [cited by applicant]
US 8235946B2 · Molgaard-Nielsen · 2012 [cited by applicant]
US 8858504B2 · Nielsen · 2014 [cited by applicant]
US 9314605B2 · Arcaro et al. · 2016 [cited by applicant]
US 9333332B2 · Eisenkolb et al. · 2016 [cited by applicant]
US 9440059B2 · Moore · 2016 [cited by applicant]
US 9592372B2 · Myers · 2017 [cited by applicant]
US 9884175B2 · Furnish et al. · 2018 [cited by applicant]
US 10155104B2 · Arcaro et al. · 2018 [cited by applicant]
US 10960198B2 · Arcaro et al. · 2021 [cited by applicant]
US 11779742B2 · Chalekian et al. · 2023 [cited by applicant]
US 20030225379A1 · Schaffer et al. · 2003 [cited by applicant]
US 20040172008A1 · Layer · 2004 [cited by applicant]
US 20080142747A1 · Jennings · 2008 [cited by examiner]
US 20110077591A1 · Plicchi et al. · 2011 [cited by applicant]
US 20110270182A1 · Breznock · 2011 [cited by examiner]
US 20150112279A1 · Myers · 2015 [cited by examiner]
US 20210146054A1 · Cully · 2021 [cited by examiner]
US 20210187269A1 · Arcaro et al. · 2021 [cited by applicant]
US 20220339419A1 · Wang · 2022 [cited by examiner]
US 20240207592A1 · Oshimizu · 2024 [cited by applicant]
US 20240245895A1 · Oshimizu · 2024 [cited by applicant]
US 20250032767A1 · Dunlea · 2025 [cited by applicant]
US 20250050071A1 · Geist et al. · 2025 [cited by applicant]
AU 2020279750B2 · 2023 [cited by applicant]
International Search Report and Written Opinion issued for PCT Application No. PCT/US2024/025981, mailed Aug. 16, 2024 (11 pages). [cited by applicant]